Medicare Enrolled

Dr. Rama Palwai, M.D.

Rheumatology · Spring, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
55 WIND RIDGE CIR, Spring, TX 77381
9363400952
In practice since 2006 (19 years)
NPI: 1689610115 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Palwai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Palwai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Palwai

Dr. Rama Palwai is a rheumatology in Spring, TX, with 19 years in practice. Based on federal Medicare data, Dr. Palwai performed 63,838 Medicare services across 709 unique beneficiaries.

Between the years covered by Open Payments, Dr. Palwai received a total of $4,357 from 32 pharmaceutical and/or device companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Palwai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 20% volume in TX$ $4,357 industry payments

Medicare Practice Summary

Medicare Utilization ↗
63,838
Medicare services
Top 20% in TX for rheumatology
709
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,360 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)36,000$4$15
Abatacept infusion (Orencia)12,300$34$75
Golimumab infusion (Simponi Aria)10,600$11$51
Infliximab infusion (Remicade)2,890$26$200
Infusion, normal saline solution, 250 cc566$1$10
Office visit, established patient (30-39 min)384$92$246
Infusion into a vein for hydration, each additional hour224$10$30
Steroid injection (triamcinolone)196$1$3
Drug injection, under skin or into muscle186$11$40
Administration of chemotherapy into vein, 1 hour or less157$103$250
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less130$50$155
Administration of chemotherapy into vein, each additional hour55$22$100
New patient office visit (45-59 min)49$118$250
Joint injection, major joint32$52$150
Office visit, established patient, complex (40-54 min)19$135$250
Aspiration and/or injection of fluid from small joint17$44$120
Office visit, established patient (20-29 min)17$71$125
Flu vaccine administration16$31$50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.8% high complexity
57.4% medium
0.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,357
Total received (2018-2024)
Avg $622/year across 7 years
Top 48% in TX for rheumatology
32
Companies
209
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,280 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$77 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$95
2023
$940
2022
$573
2021
$775
2020
$430
2019
$810
2018
$733

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,026
ABBVIE INC.
$473
Janssen Biotech, Inc.
$454
Lilly USA, LLC
$335
UCB, Inc.
$309
Novartis Pharmaceuticals Corporation
$297
AbbVie Inc.
$171
Boehringer Ingelheim Pharmaceuticals, Inc.
$156
PFIZER INC.
$142
Janssen Scientific Affairs, LLC
$110
GENZYME CORPORATION
$100
AstraZeneca Pharmaceuticals LP
$99
GlaxoSmithKline, LLC.
$90
Genentech USA, Inc.
$77
AbbVie, Inc.
$71
Horizon Therapeutics plc
$65
Mallinckrodt Hospital Products Inc.
$59
Radius Health, Inc.
$45
E.R. Squibb & Sons, L.L.C.
$34
MEDAC PHARMA, INC.
$27
Abbott Laboratories
$24
Aurinia Pharma U.S., Inc.
$24
Fresenius Kabi USA, LLC
$22
Celgene Corporation
$22
Ultragenyx Pharmaceutical Inc.
$21
Oxford Immunotec USA Inc
$19
Antares Pharma, Inc.
$18
Mallinckrodt LLC
$16
Ironwood Pharmaceuticals, Inc
$16
Horizon Pharma plc
$14
Merck Sharp & Dohme Corporation
$12
Cumberland Pharmaceuticals, Inc.
$12
Top 3 companies account for 44.8% of total payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · BENLYSTA · COSENTYX · Cimzia · Crysvita · DUZALLO · EVENITY · Enbrel · FORTEO · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · OFEV · ORENCIA · Otrexup · Proclaim Family of SCS IPGs · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · TSPOT TB TEST · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $7 per 100 Medicare services performed
Looking for a rheumatology in Spring?
Compare rheumatologys in the Spring area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
29
Per 100K population
4.4
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
3.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Palwai is a mixed practice specialist, with above-average Medicare volume (top 20% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Palwai experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Palwai performed 36,000 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Palwai receive payments from pharmaceutical companies?
Yes. Dr. Palwai received a total of $4,357 from 32 companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Palwai's costs compare to other rheumatologys in Spring?
Dr. Palwai's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Palwai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →